ijms-logo

Journal Browser

Journal Browser

Recent Advances in Cancer Chemoprevention: Focus on Natural Product

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 1300

Special Issue Editor


E-Mail Website
Guest Editor
Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy
Interests: cancer biology and therapy; angiogenesis/anti-angiogenesis; chemoprevention
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cancer is one of the most common and incurable diseases in humans, in spite of improved approaches to the detection and treatment of this pathology. Several pharmacological approaches have been developed (radiotherapy, chemotherapy, surgical intervention, target therapy) for the treatment of tumors and related metastasis; however, many counterproductive effects have been found, including multidrug resistance.

Several factors including unhealthy diet, cigarette smoking, alcohol consumption, environmental carcinogens exposure, stress, and physical inactivity, as well as hormonal factors, strictly correlate to cancer onset and dissemination. By contrast, a healthy diet coupled with the consumption of specific phytochemical compounds may play a protective role against tumor onset. According to this idea, the concept of “chemoprevention” has been recently introduced, a term that refers to natural compounds with the capability to hinder malignant transformation and dissemination with negligible side effects.

Thus, the main purpose of this Special Issue is to highlight the most relevant knowledge about the chemopreventive and antimetastatic properties of certain edible plants and fruits, as well as their extracts, emphasizing their interference with cellular and molecular events underlying tumor progression.

Dr. Domenica Mangieri
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural compounds
  • phytochemicals
  • flavonoids
  • alkaloids
  • metastatic cascade
  • apoptosis
  • autophagy
  • cell cycle
  • drug resistance
  • oxidative stress
  • epithelial–mesenchymal transition
  • signaling pathways

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

33 pages, 1829 KiB  
Review
Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading
by Valeria Naponelli, Maria Teresa Rocchetti and Domenica Mangieri
Int. J. Mol. Sci. 2024, 25(10), 5569; https://doi.org/10.3390/ijms25105569 - 20 May 2024
Viewed by 552
Abstract
Due to its propensity to metastasize, cancer remains one of the leading causes of death worldwide. Thanks in part to their intrinsic low cytotoxicity, the effects of the flavonoid family in the prevention and treatment of various human cancers, both in vitro and [...] Read more.
Due to its propensity to metastasize, cancer remains one of the leading causes of death worldwide. Thanks in part to their intrinsic low cytotoxicity, the effects of the flavonoid family in the prevention and treatment of various human cancers, both in vitro and in vivo, have received increasing attention in recent years. It is well documented that Apigenin (4′,5,7-trihydroxyflavone), among other flavonoids, is able to modulate key signaling molecules involved in the initiation of cancer cell proliferation, invasion, and metastasis, including JAK/STAT, PI3K/Akt/mTOR, MAPK/ERK, NF-κB, and Wnt/β-catenin pathways, as well as the oncogenic non-coding RNA network. Based on these premises, the aim of this review is to emphasize some of the key events through which Apigenin suppresses cancer proliferation, focusing specifically on its ability to target key molecular pathways involved in angiogenesis, epithelial-to-mesenchymal transition (EMT), maintenance of cancer stem cells (CSCs), cell cycle arrest, and cancer cell death. Full article
(This article belongs to the Special Issue Recent Advances in Cancer Chemoprevention: Focus on Natural Product)
Show Figures

Figure 1

Back to TopTop